Further Study supports use of Nevisense within new Non-melanoma Skin Cancer application
· A new clinical study from Germany including nearly 1,000 patients confirms the value of Nevisense when used to evaluate suspected Non-melanoma skin cancer (NMSC) · The study publication is an important milestone in SciBase’s strategy to broaden the areas of use and potential markets for NevisenseA new clinical study evaluating the value of using Nevisense on suspected Non-melanoma skin cancer (also known as Keratinocyte cancer) in normal clinical practice is now published. The article named “Retrospective evaluation of the performance of the electrical impedance spectroscopy system